Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?

被引：1

作者：

Bartnik, Malgorzata ^{[2
]}

Cosentino, Francesco ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Div Cardiol, Fac Med 2, Rome, Italy

[2] Skaraborg Hosp, Dept Med, Karnsjukhuset Skovde, Sweden

来源：

EUROPEAN HEART JOURNAL | 2009年 / 30卷 / 11期

关键词：

CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; EURO HEART; FOLLOW-UP; MORTALITY; RISK; COMPLICATIONS;

D O I：

10.1093/eurheartj/ehp168

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1301 / 1304

页数：4

共 28 条

[1] Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart [J].

Anselmino, Matteo ;

Oehrvik, John ;

Malmberg, Klas ;

Standl, Eberhard ;

Ryden, Lars .

EUROPEAN HEART JOURNAL, 2008, 29 (02) :177-184

[2] The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe -: The Euro Heart Survey on diabetes and the heart [J].

Bartnik, M ;

Rydén, L ;

Ferrari, R ;

Malmberg, K ;

Pyörälä, K ;

Simoons, M ;

Standl, E ;

Soler-Soler, J ;

Öhrvik, J .

EUROPEAN HEART JOURNAL, 2004, 25 (21) :1880-1890

[3] Newly detected abnormal glucose tolerance:: an important predictor of long-term outcome after myocardial infarction [J].

Bartnik, M ;

Malmberg, K ;

Norhammar, A ;

Tenerz, Å ;

Öhrvik, J ;

Rydén, L .

EUROPEAN HEART JOURNAL, 2004, 25 (22) :1990-1997

[4]

Borch-Johnsen K, 1999, LANCET, V354, P617

[5] Prevention of diabetes and cardiovascular' disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial [J].

Califf, Robert M. ;

Boolell, Mitradev ;

Haffner, Steven M. ;

Bethel, M. Angelyn ;

McMurray, John ;

Duggal, Anil ;

Holman, Rury R. .

AMERICAN HEART JOURNAL, 2008, 156 (04) :623-632

[6]

COSENTINO F, 2009, ESC TXB CAR IN PRESS

[7] The relationship between glucose and incident cardiovascular events [J].

Coutinho, M ;

Gerstein, HC ;

Wang, Y ;

Yusuf, S .

DIABETES CARE, 1999, 22 (02) :233-240

[8] Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway [J].

Dale, Ane Cecilie ;

Midthjell, Kristian ;

Nilsen, Tom Ivar ;

Wiseth, Rune ;

Vatten, Lars J. .

EUROPEAN HEART JOURNAL, 2009, 30 (11) :1372-1377

[9] Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment [J].

Danaei, Goodarz ;

Lawes, Carlene M. M. ;

Hoorn, Stephen Vander ;

Murray, Christopher J. L. ;

Ezzati, Majid .

LANCET, 2006, 368 (9548) :1651-1659

[10] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

← 1 2 3 →